Open Orphan wins €4m contract to conduct trial for new RSV treatment
- Health & Pharma
- August 10, 2020, 08:17
Dublin-listed pharmaceutical services company Open Orphan has secured a €4 million contract to trial a new treatment for respiratory syncytial virus ((...)
Inside Business with Ciaran Hancock - G7 tax deal: what was agreed and what does it mean for Ireland?